InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,962.00
(
-1.28%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.25
(
1.46%
)
Bitcoin
59,767.41
(
-5.36%
)
Post# of 252333
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RockRat

Send PM Follow Ignore
Followers 11
Posts 903
Boards Moderated 0
Alias Born 12/19/2005

RockRat

Re: DewDiligence post# 103420

Tuesday, 10/12/2010 2:21:55 AM

Tuesday, October 12, 2010 2:21:55 AM

Post# of 252333
You are aware Teva filed an ANDA for Integrilin with a paragraph IV challenge last January? It would be fun to get Teva's legal team to do the heavy lifting, then see Momenta beat it to market again. T'ain't exactly a blockbuster, though, about $300 million in sales.

http://shearlingsplowed.blogspot.com/2009/05/will-teva-market-generic-version-of.html

Notably, Teva will not get 180 day exclusivity should it prevail.

http://shearlingsplowed.blogspot.com/search/label/Integrilin%20Patent%20Teva%20Generic%20Suit%20April%2015%202010

Regards, RockRat
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up